Access cutting-edge lupus treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access lupus specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus treatment provided free
The trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this lupus clinical trial in Atlanta, GA
If you're searching for lupus treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.